Got a rev­o­lu­tion­ary health­care com­pa­ny? Bob Nelsen, Jeff Lei­den’s SPAC has $500M to take it pub­lic

ARCH Ven­tures doesn’t hold back when it can go big in biotech VC in­vest­ments. The same seems to be hold­ing true when it comes to SPACs.

Rev­o­lu­tion Health­care Ac­qui­si­tion, the blank check com­pa­ny ARCH formed in part­ner­ship with the tech play­er Gen­er­al Cat­a­lyst, raised the $500 mil­lion it asked for in an IPO. The two firms had made it clear that they will be look­ing to take a dig­i­tal health com­pa­ny pub­lic — with the end goal be­ing part of a par­a­digm shift in­volv­ing “tech­nolo­gies like wear­able sen­sors, re­mote con­tin­u­ous da­ta cap­ture, point of care di­ag­nos­tics, tele­health ca­pa­bil­i­ties and ar­ti­fi­cial in­tel­li­gence/ma­chine learn­ing tools.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER